Altering cancer cellular functions through proton mopping
Abstract
Proton mopping is a new anti-cancer therapeutic approach that disrupts cancer's immunologic balance. It results in the alteration of the pHi/pHe ratio (intracellular-extracellular) of the cancer cell, leading cancer to either normalcy or apoptosis. This technology deploys a chemical compound that has two parts, a glucose part to guide the molecule to the cancer site and a proton neutralizer to mop up the protons. Proof of the validity of this therapeutic approach came after using an existing chemical compound 2-[2(2-Aminoethoxy)ethoxy]ethyl a-D-mannopyranoside, C 12 H 25 NO 8 , which has the above mentioned properties. This compound is of the class of functionalized PEGylated glycosides, which are ligands for conjugation to biological molecules.
Claims
exact text as granted — not AI-modified1 . A new cancer therapeutic method that is based on proton (hydrogen ion) mopping.
2 . A chemical compound, according to claim 1 , which performs the proton mopping.
3 . Said chemical compound, according to claims 1 and 2 , has two parts, one for targeting cancer cells and one for mopping up the protons.
4 . Said chemical compound, according to claims 1 , 2 and 3 , further comprising the targeting part of said chemical compound to be of the glucose family or equivalent or analog to glucose.
5 . Said chemical compound, according to claims 1 , 2 and 3 , further comprising the proton mopping part to be either of the amine NH 2 family or equivalent proton acceptor.
6 . Said chemical compound, according to claim 1 , which enters the cancer cells and mops up the excess protons (hydrogen ions) produced by the cancer metabolism.
7 . Said chemical compound, according to claims 1 and 6 , which alters the pH ratio between the intracellular and the extracellular space of the cancer cells.
8 . Said chemical compound, according to claims 1 , 6 and 7 , which by altering the pHi/pHe (intra-extracellular) of the cancer cell, it alters the cancer metabolism, guiding cancer to either normalcy or apoptosis.
9 . Said chemical compound, as in any one of preceding claims, can be the existing molecule, with molecular formula C 12 H 25 NO 8 and name 2-[2(2-Aminoethoxy)ethoxy]ethyl a-D-mannopyranoside, which can perform proton mopping from the cancer cells.Join the waitlist — get patent alerts
Track US2018303862A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.